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Background: Progressive scoliosis, pelvic obliquity and increasing reduction of pulmonary function are among the
most significant problems for patients with SMA type II and SMA type III once they have lost the ability to walk. The
aim of this study was to examine and document the development and natural course of scoliosis in patients with
spinal muscular atrophy type II and IIIa.
Methods: For the purposes of a descriptive clinical study, we observed 126 patients, 99 with SMA II and 27 with SMA
IIIa and the data of scoliosis, pelvic obliquity and relative age-dependent inspiratory vital capacity were evaluated.
Results: Scoliosis and pelvic obliquity were regularly observed already in children under 4 years old in the group
with SMA II. The severity and progression of both conditions were much more pronounced in the SMA II group
than in the IIIa group. There was already a distinct reduction in relative vital capacity in the group of 4- to 6-year-
olds with SMA II.
Conclusions: The differences between the two SMA types II and IIIa described in this study should be taken into
consideration when developing new treatments and in management of scoliosis in the childhood years of these patients.
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Proximal spinal muscular atrophy (SMA) is a hereditary
autosomal recessive disease with muscular hypotonia,
hyporeflexia, symmetrical weakness and atrophy of the
skeletal muscles due to chronically degenerative alter-
ations in the anterior horn cells. It is caused by a dele-
tion or mutation in the telomeric survival motor neuron
gene (telSMN-gene, SMN1) on chromosome 5q [1,2].
Table 1 shows the classification of proximal SMA we
use in our study. Children with type II are unable to walk
but they are or were able to sit unsupported. In some cases
they are able to stand with the support of assistive devices.
The onset of SMA II usually occurs before 18 months of
age. Children with type IIIa and IIIb are or were able to* Correspondence: a.fujak@t-online.de
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reproduction in any medium, provided the orwalk. Type IIIa manifests itself up to the age of three years
and type IIIb over the age of three years to the age of
thirty years. The subdivision of type III is in our opinion
important for children’s orthopaedics. The course of the
disease and treatment strategies are different in types IIIa
and IIIb [3].
The fundamental orthopaedic problem for patients
with SMA type II and IIIa is progressive scoliosis with
increasing pelvic obliquity and seated instability, reduced
lung function and contractures in the lower and upper
extremities [4-8].
To date there is no causal therapy for SMA. The
course of the disease and the patient’s quality of life can
be greatly improved by established medical procedures
[3,5,6]. Orthopaedic treatment of scoliosis and pelvic ob-
liquity is of great importance for SMA patients. It in-
cludes conservative methods such as corsets up to the
point when surgery is definitely indicated, in order totd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Classification and prognosis of different types of autosomal recessive proximal spinal muscular atrophy [1,2]
Types Manifestation Functional grading Life expectancy
Ia more severe prenatal (30%) to 3-6 months unable to roll over or sit < 30 months = 100%
< 18 months = 95%
< 7 months = 50%
Ib less severe like Ia like Ia 2.5 - 20 years *
II intermediate birth -18 months sitting 2.5 - 30 years *
IIIa mild, retarded motor development to 3 years walking 4th – 6th decade, usually normal
IIIb mild, normal motor development > 3 - 30 years walking
IV adult > 30 years walking normal
* Longer life expectancy is quite possible.
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stabilisation of the spine.
The purpose of this study is to determine the develop-
ment and course of scoliosis, pelvic obliquity and vital
capacity in patients with the intermediate SMA form
(type II) and mild SMA form with retarded motor devel-
opment (type IIIa) following a survey of 126 patients. It
is becoming increasingly difficult to find such data since
spinal surgery is nowadays being carried out on many
children at ever earlier ages.
Methods
The data were collected during special nationwide ortho-
paedic consultations for patients with neuromuscular dis-
orders from 1999 to 2010. All SMA patients with evident
scoliosis without surgery examined during that time
period were included in this study. 126 patients with
SMA, 99 with SMA type II and 27 with SMA type IIIa, 61
male patients and 65 female were evaluated. 41 patients,
37 with SMA type II and 4 with type IIIa, were excluded
because they had already had spine surgery.
Diagnosis was confirmed either genetically (79 patients)
or by muscle biopsy and neurophysiology (47 patients).
The diagnosis in the older patients was confirmed by
muscle biopsy and neurophysiology because genetic diag-
nostics in SMA developed gradually after 1995.
The average age at diagnosis was 1.6 years (± 0.9, 0.1 –
6) in the SMA II group and 3.1 years (± 1.5, 1.5 – 6.9) in
the SMA IIIa group. For this study we examined children
and young people from infancy to 20 years old.
The SMA II patients were by definition never able to
walk unaided. We found that 24 SMA II patients started
to sit unsupported at an average age of one year (± 1.3,
0.3 – 6, median 0.6). Many patients were able to sit un-
supported by their last follow-up examination.
20 patients with SMA IIIa began to walk unaided at
1.4 years on average (± 0.6, 0.8 – 3, median 1.3) and 15
patients from this group were unable to walk unaided at
an average age of 7.4 years (± 3.9, 1.5 – 14, median 8).
The scoliosis and pelvic obliquity were given clinical
and radiological examinations. The radiographs weretaken in two planes in a sitting position. A spirometry
test was carried out from the age of 4 to 6 in order to
assess pulmonary function. In this article, the values of
the relative age-dependent inspiratory vital capacity (VC
IN%) are evaluated.
This is a descriptive clinical study with retrospective
data collection.
This study is in accordance with the ethical standards of
the relevant local Ethics Commission (Research Ethics
Committee, Faculty of Medicine, Department of Ortho-
paedic Surgery, Friedrich-Alexander-Universität Erlangen-
Nürnberg, EK_No. 61_12 Bc).
Results
Of the 99 patients with SMA II, 87 had C-shaped scoli-
osis (84 major thoracolumbar curves, 2 thoracic and one
lumbar) and 12 had S-shaped scoliosis. Of the 27 pa-
tients with SMA IIIa, 18 had C-shaped scoliosis (all
major thoracolumbar curves) and 9 (33%) had S-shaped
scoliosis.
Of the S-shaped scoliosis, the main curve in SMA II
patients was thoracic in 6 cases, lumbar in 4 and thora-
columbar in 2. In type IIIa patients, the main curve was
thoracic in 6 cases and lumbar in 3.
Of the C-shaped scoliosis, there were 56 curves to the
left and 31 right convex in type II patients, and 10
curves to the right and 8 left convex in type IIIa patients.
The main curve of S-shaped scoliosis in type II was right
convex in 4 cases and left convex in 8 cases. The main
curve in 6 type IIIa patients with S-shaped scoliosis was
right convex and left convex in 3 patients.
We regularly observed scoliosis and pelvic obliquity in
the group with SMA II, even in children in the age group
0 to 4 years old. The maximum curve in this young group
was 40° and the pelvic tilt was 10° (Table 2). The average
scoliosis of the 14- to 15-year-olds was 82° with a max-
imum of 112°. The pelvic tilt in this age-group reached an
average of 26° and a maximum of 45° (Table 2).
The prevalence, severity and progression of the scoli-
osis and pelvic obliquity were much more marked in
SMA II patients than in the SMA IIIa group (Table 2).
Table 2 Average main curvature and pelvic obliquity in SMA II and IIIa non-surgery patients
Patient’s age (years) n Ø, ±, min – max, median n Ø, ±, min – max, median
Main curve of the scoliosis (Cobb angle °)
SMA II (N = 58) SMA IIIa (N = 12)
0 - 4 9 Ø 26, ± 7, 15 - 40, 25 1 28
5 - 6 10 Ø 42, ± 19, 12 - 70, 37 2 28 and 32
7 - 10 25 Ø 63, ± 32, 17 - 138, 58 3 Ø 34, ± 8.5, 25 - 42, 35
11 - 13 6 Ø 74, ± 16, 56 - 102, 72.5 2 42 and 51
14 - 15 4 Ø 82, ± 28, 50 - 112, 83.5 1 54
16 - 20 4 Ø 73, ± 18, 58 - 100, 67.5 3 Ø 45, ± 8, 40 - 54, 42
Pelvic obliquity (°)
SMA II (N = 72) SMA IIIa (N = 18)
0 - 4 5 Ø 7, ± 4.5, 0 - 10, 10 - -
5 - 6 12 Ø 17, ± 7, 0 - 30, 15 1 10
7 - 10 36 Ø 18, ± 10, 0 - 45, 15 3 Ø 10, ± 10, 0 - 20, 10
11 - 13 7 Ø 19, ± 15, 0 - 45, 20 5 Ø 10, ± 10, 0 - 20, 10
14 - 15 8 Ø 26, ± 13, 0 - 45, 27.5 5 Ø 8, ± 11, 0 - 20, 0
16 - 20 4 Ø 24, ± 18, 0 - 40, 27.5 4 Ø 14, ± 5, 10 - 20, 12.5
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average of 54% in the relative vital capacity among the
4- to 6-year-olds with SMA II (Table 3). In comparison,
we observed considerably better values in the SMA IIIa
group, even among the older children (Table 3). The re-
duction of vital capacity was progressive with age in
both groups but distinctly much more pronounced
among SMA II patients than SMA IIIa (Table 3).Discussion
This study documents that scoliosis in patients with
SMA II and SMA IIIa develops early and progresses
rapidly and that their vital capacity deteriorates during
childhood. The difference in how the conditions pro-
gress in the two groups becomes clear. In general, we
verified that the course of scoliosis, pelvic obliquity
and pulmonary function is on average milder in SMA
IIIa patients than in SMA II patients [9,10]. C-shaped
scoliosis predominates in both groups but there is a
larger proportion of S-shaped curves among the IIIa
group (33%) than among the SMA II group (12%).Table 3 Relative age-dependent inspiratory vital capacity (VC
VC IN% SMA II (N = 40)
Patient’s age (years) n Ø, ±, min – max
4 - 6 5 Ø 54, ± 13, 41 -
7 - 10 19 Ø 44, ± 21, 14 -
11 - 13 9 Ø 37, ± 22, 10 -
14 - 15 3 Ø 37, ± 11, 25 -
16 - 20 4 Ø 42, ± 18, 25 -Since surgical treatment for SMA patients who are un-
able to walk and who have progressive scoliosis with pel-
vic tilt is now well-established from the age of about 10
to 12 years old, there is less and less data about the nat-
ural course of the condition at our disposal [2,4,5,11-22].
However, we know from earlier studies that scoliosis in-
creases over the course of time, leading to the loss of
stability when sitting and a negative impact on everyday
activities [9-13,15,17,18].
Our observations correlate with earlier studies
[9,10,17,19,20]. Granata et al. [9] state that scoliosis in
SMA II patients progresses by 8° per year and in SMA IIIa
patients unable to walk by 3° per year [9,17]. According to
Rodillo et al. [10], scoliosis in SMA patients progresses by
between 5° and 15° per year.
Fitting a corset cannot halt the progression of scoliosis
in SMA [10-18,23]. It can only improve seated stability
temporarily, replace the use of arms to support the
seated position and help to bridge the time until surgical
stabilisation of the spine.
Our group of patients is made up of patients of diffe-
rent ages who came to our nationwide special orthopaedicIN%) in SMA II and IIIa non-surgery patients
SMA IIIa (N = 15)
, median n Ø, ±, min – max, median
70, 58 - -
91, 43 4 Ø 80, ± 23, 56 - 108, 78
86, 32 5 Ø 56, ± 24, 17 - 73, 70
47, 39 6 Ø 43, ± 11, 31 - 63, 40
63, 43 - -
Fujak et al. BMC Musculoskeletal Disorders 2013, 14:283 Page 4 of 5
http://www.biomedcentral.com/1471-2474/14/283consultations for neuromuscular disorders. Some of these
patients have been regularly in our orthopaedic care since
early childhood. This is a biased cohort of patients because
our patients had visited us because of orthopaedic prob-
lems like contractures and scoliosis. The disadvantage of
this study is the small amount of data, especially for small
children and for older adolescents. Many children were
given only a clinical examination, despite their existing
scoliosis. X-ray images were not taken at every examin-
ation since they would have had no therapeutic effect. X-
ray examinations were mostly made for initial findings,
before a corset was supplied or where an indication for
surgical stabilisation of the spine was in question.
Testing vital capacity in small children was not always
possible, sometimes because they were unwilling to com-
ply and sometimes because of technical reasons: there was
often no mouthpiece for the spirometer to suit the chil-
dren’s size and anatomy.
41 patients had already had surgical stabilisation of
the spine at an average age of 9.9 years (4.8 -22.7) [24].
Data about older adolescents with severe scoliosis
could be gathered only if the patients presented at our
clinic for the first time at a later age or if earlier surgical
treatment had been declined or had not been possible.
It is for these reasons that data about patients older
than 13 years is less conclusive. The course of the data
for this age-group in Tables 2 and 3 is largely caused by
the fact that most patients with severe scoliosis had
already been operated on.
This study has made clear that the vital capacity of
both SMA II and SMA IIIa patients decreases systemat-
ically as they grow [10,13,19,20]. However, there are
already 4- to 6-year-olds with SMA II with marked re-
duction which we mostly see in the SMA IIIa group
after 10 years old. The pulmonary function values in
young people with SMA II seem to stabilise after their
greatest time of growth. We have seen some patients
who have kept stable values far into adult life.
This study presents cross sectional data, so that it can-
not be concluded that every SMA patient with SMA type
II or IIIa would experience exactly the same course as de-
scribed. Significant individual differences are observed.
The mean age of sitting independently at an average
age of one year seems to be surprisingly late for SMA II
patients. It could be an indication for a biased cohort of
patients, referred to the evaluated group due to the fact
that scoliosis had already developed. Delayed sitting may
be predictive of the severity of weakness indicating a
higher risk for scoliosis.
This study highlights the need for a comprehensive
strategy to prospectively identify and follow all SMA pa-
tients from an early age and monitor them for the
course of disease, development and progression of scoli-
osis, pelvic obliquity and the respiratory insufficiency.We recommend starting to monitor of SMA patients
regularly by clinical examination in the special ortho-
paedic consultation as early as possible to determine an
individual strategy in the provision of corsets, orthoses
and orthopaedic technical devices and to determine the
time for operative spine stabilisation [3]. The aims of the
orthopaedic management are stabilise, optimise and
maintain the sitting and standing position and the ability
to walk [3]. If scoliosis will be diagnosed in the clinical
examination the radiographs in two planes in a sitting
position without corset should be done to verify the
scoliosis [24]. The course of scoliosis and pelvic obli-
quity could be monitored and documented by clinical
examination. We recommend monitoring the patients
every 3 to 12 months depending on the dynamics of the
disease and child development and growth. Usually ra-
diographs are not necessary with each examination. We
recommend radiographs for special circumstances, such
as the provision of corsets or an indication for spinal
surgery [3,24].
The results of this study can be used as the basis for
the evaluation and further development of surgical treat-
ments of scoliosis in SMA patients, particularly in their
early growth period [24-26]. Here it is important to
know the differences between the two SMA types, type
II and IIIa, in order to calculate the expected course of
the condition, and to choose the best treatment and the
right time for surgery.
Conclusions
Differentiating SMA types II, IIIa and IIIb is very im-
portant in order to be able to assess correctly the prog-
nosis of the development of scoliosis, pelvic obliquity
and pulmonary insufficiency. The development of
scoliosis, pelvic obliquity and reduction of pulmonary
function in patients with SMA II and IIIa are investi-
gated and compared accurately. Patients with SMA II
are clearly affected earlier and more distinctly than pa-
tients with SMA IIIa, making the treatment of SMA II
more difficult.
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